Repligen
RGEN
429 hedge funds and large institutions have $9.28B invested in Repligen in 2021 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 132 increasing their positions, 158 reducing their positions, and 81 closing their positions.
34% more call options, than puts
Call options by funds: $45.5M | Put options by funds: $33.8M
1.24% more ownership
Funds ownership: 83.49% → 84.74% (+1.2%)
5% more capital invested
Capital invested by funds: $8.88B → $9.28B (+$406M)
6% less funds holding
Funds holding: 458 → 429 (-29)
16% less repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 158
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
35% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 81
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$106M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$84.6M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$68.8M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$66.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$57.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$49.8M |
| 2 |
Bank of New York Mellon
New York
|
-$49M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$46.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$43.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$31.6M |
RGEN Hedge Fund Activity: Q2 2021 in Review
429 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q2 2021, worth a combined $9.28B — up 4.6% from $8.88B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of RGEN and 53 opened new positions — a net loss of 28 holders — while 158 trimmed existing stakes and 132 added.
The largest buyer was BlackRock, adding an estimated $106M. The largest seller was JP Morgan Chase, cutting an estimated $49.8M.
- 429 institutional investors held Repligen (RGEN) as of Q2 2021, down from 458 in Q1 2021.
- Funds reported $9.28B of Repligen stock for Q2 2021, up 4.6% quarter-over-quarter.
- 53 funds opened new Repligen positions in Q2 2021 and 81 closed out, a net change of -28 holders.
- The largest Repligen buyer in Q2 2021 was BlackRock, an estimated $106M added.
- The largest Repligen seller in Q2 2021 was JP Morgan Chase, an estimated $49.8M sold.
Based on aggregated 13F filings for Q2 2021.